send to a friend by email

Jerusalem Pharmaceuticals earns a pretax income of JD0.40 million in Q1 2011

2011-05-03

Jerusalem Pharmaceuticals JPH disclosed its financial results for the first quarter of this year, where they indicated a pretax income of JD401,499 compared to an income of JD776,525 in the first quarter of 2010. Total assets reached JD29,570,597 on 31/03/2011 compared to JD28,745,051 as of 31/12/2010. Total Liabilities amounted at JD6,627,378 on 31/03/2011 after they reached JD6,187,869 on 31/12/2010. Total shareholders’ equity settled at 22,943,219 (minatory interest of JD14,914) at the end of the first quarter of 2011 compared to $27,877,328 (minatory interest of JD76,538)at the end of 2010.